Technology Transfers To Least-Developed Countries Often Not An Option - IFPMA Report
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The transfer of technology developed by high-end research-based pharmaceutical companies to operations in developing countries is increasingly common, but rarely simple
You may also be interested in...
U.S. AIDS Assistance Unable To Transfer To Local Ownership In Emerging Markets Like Africa
PEPFAR-supported countries are not ready to take over their AIDS programs as projected, in part because of the financial crisis.
BMS Launches Pilot Program With WHO In Five African Countries
Bristol-Myers Squibb is scaling up its community-based tuberculosis interventions to support HIV-positive populations in Africa. The U.S. drug maker's charity wing, Bristol-Myers Squibb Foundation signed a collaboration agreement with the World Health Organization and committed $1.2 million to help develop a global guidance involving national TB programs to fight tuberculosis
BMS Launches Pilot Program With WHO In Five African Countries
Bristol-Myers Squibb is scaling up its community-based tuberculosis interventions to support HIV-positive populations in Africa. The U.S. drug maker's charity wing, Bristol-Myers Squibb Foundation signed a collaboration agreement with the World Health Organization and committed $1.2 million to help develop a global guidance involving national TB programs to fight tuberculosis